
    
      Prostate cancer patients for which reimbursed ADT with a gonadoliberin antagonist is
      indicated, for a period of at least 6 months will lbe enrolled. At 0, 3 months and 6 months
      of ADT, Aging Males' Symptoms (AMS), EQ-5D (EuroQoL), and hot flashes intensity and frequency
      (Moyad scale) will be collected, as well as routine assessments: vital signs (blood pressure,
      heart rate), weight, waist perimeter, fat percentage, Body Mass Index (BMI) and routine
      laboratory assessments. Determine genotypes of polymorphisms of interest by pyrosequencing.
      Determine the prevalence of the polymorphisms of interest in the studied population. Perform
      initial assessment of the association between genetic polymorphisms and questionnaire
      results.
    
  